Drug Patent Expirations in November 2010

*Drugs may be covered by multiple patents

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
SAMSCA	Otsuka America Pharm	tolvaptan	5,258,510	Nov 2, 2010
TRUVADA	Gilead	emtricitabine; tenofovir disoproxil fumarate	5,210,085*PED	Nov 11, 2010
COZAAR	Merck	losartan potassium	5,210,079*PED	Nov 11, 2010
EMTRIVA	Gilead	emtricitabine	5,210,085*PED	Nov 11, 2010
ATRIPLA	Gilead	efavirenz; emtricitabine; tenofovir disoproxil fumarate	5,210,085*PED	Nov 11, 2010
TAXOTERE	Sanofi Aventis Us	docetaxel	4,814,470*PED	Nov 14, 2010
GEMZAR	Lilly	gemcitabine hydrochloride	4,808,614*PED	Nov 15, 2010
RAPAMUNE	Wyeth Pharms Inc	sirolimus	5,212,155*PED	Nov 18, 2010
FORTOVASE	Hoffmann La Roche	saquinavir	5,196,438	Nov 19, 2010
INVIRASE	Hoffmann La Roche	saquinavir mesylate	5,196,438	Nov 19, 2010
INVIRASE	Roche	saquinavir mesylate	5,196,438	Nov 19, 2010
VITRAVENE PRESERVATIVE FREE	Novartis	fomivirsen sodium	5,264,423	Nov 23, 2010
PEPCID AC	Merck Sharp Dohme	famotidine	5,075,114*PED	Nov 23, 2010
PEPCID COMPLETE	Merck Sharp Dohme	calcium carbonate; famotidine; magnesium hydroxide	5,075,114*PED	Nov 23, 2010
ADALAT CC	Bayer Hlthcare	nifedipine	5,264,446	Nov 23, 2010
PROCARDIA XL	Pfizer	nifedipine	5,264,446	Nov 23, 2010
ARICEPT ODT	Eisai Inc	donepezil hydrochloride	4,895,841	Nov 25, 2010
ARICEPT	Eisai Inc	donepezil hydrochloride	4,895,841	Nov 25, 2010
HYCAMTIN	Smithkline Beecham	topotecan hydrochloride	5,004,758*PED	Nov 28, 2010
BUTRANS	Purdue Pharma Lp	buprenorphine	5,240,711	Nov 28, 2010